Home / Generics

Generics

News

Teva settles patent litigation over ProAir HFA posted 04/07/2014

The world’s biggest generics maker, Teva Pharmaceutical Industries (Teva), announced on 20 June 2014 that it had reached a se...

Actavis settles Nuvigil patent litigation, challenges Onglyza patent posted 20/06/2014

US generics major Actavis has settled patent litigation related to Actavis’ generic version of Nuvigil (armodafinil) and conf...

First generic celecoxib approved by FDA posted 16/06/2014

The US Food and Drug Administration (FDA) announced on 30 May 2014 that it had approved the first generic versions of celecox...

Sun Pharma’s Gujarat site under FDA import alert posted 06/06/2014

Sun Pharmaceutical Industries’ (Sun Pharma) response to the US import ban on products produced at the company’s Gujarat site...

Novartis settles Gleevec lawsuit with Sun Pharma posted 03/06/2014

Sun Pharmaceutical Industries (Sun Pharma) announced on 15 May 2014 that it had reached a settlement agreement with originato...

 

Research

Patent term restoration provisions in CETA posted 18/07/2014

Some of the provisions included in the Comprehensive Economic and Trade Agreement (CETA) between the European Union (EU) and...

Influence of CETA on generics posted 04/07/2014

On 18 October 2013, the European Union (EU) and Canada reached a political agreement on the key elements for a Comprehensive...

Factors influencing use of generic asthma drugs in Morocco posted 20/06/2014

Despite the introduction of methods to promote the use of generics, use of generic anti-asthmatic drugs remains limited in Mo...

Promoting generics prescribing in the UK posted 16/06/2014

Possible ways to encourage more prescribing of generics in the UK include financial incentives with educational intervention...

Impact of price cuts on spending on hyperlipidaemic drugs in South Korea posted 10/06/2014

Rapidly increasing pharmaceutical expenditures have become a constant challenge to the sustainability of healthcare systems a...

 

General

European regulators give green light to Ranbaxy plant posted 13/06/2014

In what comes as good news for generics maker Ranbaxy, European Regulators have cleared the company’s Toansa plant.

FDA’s faster approval of generics to benefit Indian drugmakers posted 03/06/2014

Indian generics makers are set to benefit from performance goals set by the US Food and Drug Administration (FDA) as part of...

Natco tries to block hepatitis C patent in India posted 23/05/2014

Indian generics maker Natco Pharma (Natco) has asked the Indian patent office not to issue a patent for US-based Gilead Scien...

Generics applications under review by EMA – April 2014 posted 09/05/2014

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

UK launches generic medicines forum posted 02/05/2014

The UK’s drug regulatory agency, the Medicines and Healthcare products Regulatory Agency (MHRA) and the British Generic Manuf...

Generics News Research General

more

Biosimilars News Research General

more